These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 18007080)
1. [Clinical significance of the expression of the RCAS1 mRNA and protein in astrocytic tumors]. Shen CF; Yuan XR; Qin ZQ Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Oct; 32(5):836-9. PubMed ID: 18007080 [TBL] [Abstract][Full Text] [Related]
2. [Expressions of peroxiredoxin 1, peroxiredoxin 6 and GFAP in human brain astrocytoma and their clinical significance]. Zhou J; Liu Q; Wang J; Guo X; Song L Nan Fang Yi Ke Da Xue Xue Bao; 2012 Sep; 32(9):1255-9. PubMed ID: 22985558 [TBL] [Abstract][Full Text] [Related]
4. Expression of the Ets-1 proto-oncogene correlates with malignant potential in human astrocytic tumors. Kitange G; Kishikawa M; Nakayama T; Naito S; Iseki M; Shibata S Mod Pathol; 1999 Jun; 12(6):618-26. PubMed ID: 10392639 [TBL] [Abstract][Full Text] [Related]
5. Gene and protein expression of RCAS1 in hepatocellular carcinoma. Ikeguchi M; Hirooka Y; Kaibara N Anticancer Res; 2003; 23(6D):4967-71. PubMed ID: 14981953 [TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical analysis of metallothionein in astrocytic tumors in relation to tumor grade, proliferative potential, and survival. Hiura T; Khalid H; Yamashita H; Tokunaga Y; Yasunaga A; Shibata S Cancer; 1998 Dec; 83(11):2361-9. PubMed ID: 9840536 [TBL] [Abstract][Full Text] [Related]
7. Grade-specific expression of insulin-like growth factor-binding proteins-2, -3, and -5 in astrocytomas: IGFBP-3 emerges as a strong predictor of survival in patients with newly diagnosed glioblastoma. Santosh V; Arivazhagan A; Sreekanthreddy P; Srinivasan H; Thota B; Srividya MR; Vrinda M; Sridevi S; Shailaja BC; Samuel C; Prasanna KV; Thennarasu K; Balasubramaniam A; Chandramouli BA; Hegde AS; Somasundaram K; Kondaiah P; Rao MR Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1399-408. PubMed ID: 20501753 [TBL] [Abstract][Full Text] [Related]
8. Geminin: a good prognostic factor in high-grade astrocytic brain tumors. Shrestha P; Saito T; Hama S; Arifin MT; Kajiwara Y; Yamasaki F; Hidaka T; Sugiyama K; Kurisu K Cancer; 2007 Mar; 109(5):949-56. PubMed ID: 17262828 [TBL] [Abstract][Full Text] [Related]
9. Telomerase activity and alterations in telomere length in human brain tumors. Hiraga S; Ohnishi T; Izumoto S; Miyahara E; Kanemura Y; Matsumura H; Arita N Cancer Res; 1998 May; 58(10):2117-25. PubMed ID: 9605755 [TBL] [Abstract][Full Text] [Related]
10. Expression of survivin in astrocytic tumors: correlation with malignant grade and prognosis. Kajiwara Y; Yamasaki F; Hama S; Yahara K; Yoshioka H; Sugiyama K; Arita K; Kurisu K Cancer; 2003 Feb; 97(4):1077-83. PubMed ID: 12569609 [TBL] [Abstract][Full Text] [Related]
11. Differential expression of the RNA-binding motif protein 3 in human astrocytoma. Zhang HT; Zhang ZW; Xue JH; Kong HB; Liu AJ; Li SC; Liu YX; Xu DG Chin Med J (Engl); 2013; 126(10):1948-52. PubMed ID: 23673116 [TBL] [Abstract][Full Text] [Related]
12. Classification of human astrocytic gliomas on the basis of gene expression: a correlated group of genes with angiogenic activity emerges as a strong predictor of subtypes. Godard S; Getz G; Delorenzi M; Farmer P; Kobayashi H; Desbaillets I; Nozaki M; Diserens AC; Hamou MF; Dietrich PY; Regli L; Janzer RC; Bucher P; Stupp R; de Tribolet N; Domany E; Hegi ME Cancer Res; 2003 Oct; 63(20):6613-25. PubMed ID: 14583454 [TBL] [Abstract][Full Text] [Related]
13. p53 protein overexpression in astrocytic neoplasms. Cho MY; Jung SH; Kim TS Yonsei Med J; 1995 Dec; 36(6):521-6. PubMed ID: 8599254 [TBL] [Abstract][Full Text] [Related]
14. Expression of Kir 4.1 in human astrocytic tumors: correlation with pathologic grade. Tan G; Sun SQ; Yuan DL Biochem Biophys Res Commun; 2008 Mar; 367(4):743-7. PubMed ID: 18191638 [TBL] [Abstract][Full Text] [Related]
15. Amplification of the epidermal growth factor receptor in astrocytic tumours by chromogenic in situ hybridization: association with clinicopathological features and patient survival. Järvelä S; Helin H; Haapasalo J; Järvelä T; Junttila TT; Elenius K; Tanner M; Haapasalo H; Isola J Neuropathol Appl Neurobiol; 2006 Aug; 32(4):441-50. PubMed ID: 16866989 [TBL] [Abstract][Full Text] [Related]
16. High ATP2A2 expression correlates with better prognosis of diffuse astrocytic tumor patients. Li WQ; Zhong NZ; He J; Li YM; Hou LJ; Liu HM; Xia CY; Wang LZ; Lu YC Oncol Rep; 2017 May; 37(5):2865-2874. PubMed ID: 28339043 [TBL] [Abstract][Full Text] [Related]
17. Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas. Hartmann C; Hentschel B; Wick W; Capper D; Felsberg J; Simon M; Westphal M; Schackert G; Meyermann R; Pietsch T; Reifenberger G; Weller M; Loeffler M; von Deimling A Acta Neuropathol; 2010 Dec; 120(6):707-18. PubMed ID: 21088844 [TBL] [Abstract][Full Text] [Related]
18. Reduced expression of PDCD5 is associated with high-grade astrocytic gliomas. Li H; Wang Q; Gao F; Zhu F; Wang X; Zhou C; Liu C; Chen Y; Ma C; Sun W; Zhang L Oncol Rep; 2008 Sep; 20(3):573-9. PubMed ID: 18695908 [TBL] [Abstract][Full Text] [Related]
19. High frequency of p53 protein accumulation without p53 gene mutation in human juvenile pilocytic, low grade and anaplastic astrocytomas. Lang FF; Miller DC; Pisharody S; Koslow M; Newcomb EW Oncogene; 1994 Mar; 9(3):949-54. PubMed ID: 8108140 [TBL] [Abstract][Full Text] [Related]
20. hTERT immunopositivity patterns in the normal brain and in astrocytic tumors. Kotoula V; Cheva A; Barbanis S; Papadimitriou CS; Karkavelas G Acta Neuropathol; 2006 Jun; 111(6):569-78. PubMed ID: 16614861 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]